MTOR and endometrial cancer: Consistent with these observations, our pre-clinical studies reveal that metformin inhibits cell proliferation in endometrial cancer cell lines through inhibition of mTOR signaling, and behaves as a chemosensitizer when combined with cytotoxic agents 16,17.